HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: May 07, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 888.25 as of 07 May 14:04.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.4 on March 2024 . This represents a CAGR of 21.01% over 5 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 19309 crore on March 2024 . This represents a CAGR of 13.93% over 5 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the decline of -100%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the decline of -100%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 32.44 % on March 2024 . This represents a CAGR of 10.77% over 5 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Alembic Pharmaceuticals Ltd News Hub

News

Board of Alembic Pharmaceuticals recommends final dividend

Alembic Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

06 May 2025 14:39

News

Alembic Pharma slips after Q4 PAT drops 12% YoY to Rs 157 cr

Revenue from operations grew 16.66% year on year (YoY) to Rs 1,769.64 crore in the quarter...

Read more

06 May 2025 15:26

News

Alembic Pharmaceuticals receives USFDA final approval for Ticagrelor Tablets

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

02 May 2025 14:55

News

Alembic Pharma gains after receiving EIR from USFDA for Panelav facility

The company announced in an exchange filing that the EIR pertains to an inspection conduct...

Read more

30 Apr 2025 13:17

News

Alembic Pharmaceuticals commissions new facility at Pithampur, Madhya Pradesh

Alembic Pharmaceuticals has commissioned a new manufacturing facility located at Pithampur...

Read more

26 Apr 2025 14:24

News

Alembic Pharmaceuticals to conduct board meeting

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

19 Apr 2025 10:36

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct board meeting

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 14 May 2025...

Read more

30 Apr 2025 10:45

News

Piramal Pharma's Telangana unit starts production of general anesthesia drug Sevoflurane

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility ...

Read more

02 Apr 2025 11:25

News

Piramal Pharma Ltd Spurts 3.8%

Piramal Pharma Ltd rose 3.8% today to trade at Rs 229.65. The BSE Healthcare index is up 0...

Read more

21 Mar 2025 09:30

News

Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit

In a regulatory filing made after market hours yesterday, the pharmaceutical company state...

Read more

19 Feb 2025 09:37

News

Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore

Profit before tax stood at Rs 66.80 crore in the December 2024 quarter, registering a grow...

Read more

29 Jan 2025 11:53

News

Piramal Pharma launches Chlorpromazine Hydrochloride in US

Chlorpromazine Hydrochloride Injection is a medicine used to treat various disorders such ...

Read more

23 Jan 2025 09:38

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Piramal Pharma Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 17,446 Cr while Market cap of Piramal Pharma Ltd is 27,403 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd?

As of May 7, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹887.6. On the other hand, Piramal Pharma Ltd stock price is INR ₹206.7.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions